Tay, R Y <br/><br/>
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  07 2019 
 - 1114-1120 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdz122  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy<br/>Disease Progression<br/>Dose Fractionation, Radiation<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplastic Cells, Circulating--drug effects<br/>Small Cell Lung Carcinoma--blood<br/>Survival Rate